Publications by authors named "Stuart D Oliver"

Claim this Profile
P
Phase I study assessing the safety and tolerability of barasertib (AZD1152) with low-dose cytosine arabinoside in elderly patients with AML.
Hagop M Kantarjian, Mikkael A Sekeres, Vincent Ribrag, Philippe Rousselot, Guillermo Garcia-Manero, Stuart D Oliver

Clin Lymphoma Myeloma Leuk· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disposition and metabolism of the specific endothelin A receptor antagonist zibotentan (ZD4054) in healthy volunteers.
Jacqueline A Clarkson-Jones, Alison S J Kenyon, John Kemp, Eva M Lenz, Stuart D Oliver

Xenobiotica· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An open-label, randomized, single-center, two-period, phase I, crossover study of the effect of zibotentan (ZD4054) on the pharmacokinetics of midazolam in healthy male volunteers.
Helen K Tomkinson, John V Kemp, Thomas Wollseifen, Thomas Morris, Stuart D Oliver

Clin Ther· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The pharmacokinetics and safety of intravenous voriconazole - a novel wide-spectrum antifungal agent.
Lynn Purkins, Nolan Wood, Katie Greenhalgh, Malcolm D Eve, Stuart D Oliver

Br J Clin Pharmacol· December 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Voriconazole, a novel wide-spectrum triazole: oral pharmacokinetics and safety.
Lynn Purkins, Nolan Wood, Katie Greenhalgh, Michael J Allen, Stuart D Oliver

Br J Clin Pharmacol· December 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metabolism and disposition of the antihypertensive agent moxonidine in humans.
Minxia M He, Trent L Abraham, Thomas J Lindsay, Hans C Schaefer, Isabelle J Pouliquen, Stuart D Oliver

Drug Metab Dispos· March 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacodynamic effect of continuous vs intermittent dosing of dofetilide on QT interval.
Michael J Allen, Stuart D Oliver, Margaret W Newgreen, Donald J Nichols

Br J Clin Pharmacol· January 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis